ASGE Interventional IBD: Management of Complications (On-Demand)| March 2022-Colitis-associated Neoplasia: Cut, Burn or Send to Cut

Video Transcription

Video Summary

In this video, Dr. Udai Namanathan discusses the management of dysplasia in patients with inflammatory bowel disease (IBD). He begins by noting that not all patients with dysplasia require referral to colorectal surgery. He explains that cancer development in patients with IBD is different from that in patients without IBD, as it often presents as non-polypoid lesions with different mutations. Dr. Namanathan emphasizes the importance of accurately describing and assessing the lesions before deciding on the appropriate approach for resection. He discusses the techniques of endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD) for resecting the lesions, highlighting the need for clear margins and the possibility of ablation around the resection site to decrease the risk of recurrence. He also mentions the challenges and controversies surrounding surveillance and follow-up for these patients. Dr. Namanathan acknowledges the need for further research in this area. The video does not provide any specific credits.

Asset Subtitle

Udayakumar Navaneethan, MD, FASGE

Keywords

management of dysplasia

inflammatory bowel disease

referral to colorectal surgery

endoscopic mucosal resection

endoscopic submucosal dissection